Gastrointestinal Cancer Research
Help back the next breakthrough
Gastrointestinal Cancer at a Glance
It is estimated that over 27,000 Australians will be diagnosed with a gastrointestinal cancer in 2025, including bowel, pancreatic, liver, stomach and oesophageal cancers.*
Continued research is critical to improving outcomes - Cure Cancer supports the work of emerging researchers investigating new ways to detect, understand and treat all cancer types, including gastro-intestinal cancer.
Our Gastro-intestinal Cancer Research
"My project’s a fresh incentive which brings together collaborators with immunology and cancer expertise. Without this important funding from Cure Cancer, my work wouldn’t be possible"
Dr Lisa Mielke, a Cure Cancer grant recipient
Meet some of our Gastrointestinal Cancer Researchers
Dr Kevin Fenix
Dr Jennifer Currenti
Dr Peter Georgeson
Dr Lisa Mielke
Why Research Funding Matters
Many of Australia's leading cancer researchers received funding from Cure Cancer at the earliest stages of their careers. Some have gone on to make discoveries recognised around the world.
Emerging researchers drive the breakthroughs that shape how cancer is understood and treated - but early-career funding is scarce and highly competitive. Every donation helps Cure Cancer back the next generation of researchers in Australia, across all cancer types.
How Your Donation Helps
$75
Can help fund an hour of research
$125
Can help fund microscopy imaging to look for immune cells in tumours
$550
Can help fund lab supplies for up to ten vital experiments
$1,000
Can help provide cutting-edge software to analyse cells
Learn More About Gastro-intestinal Cancer
What is gastrointestinal cancer?
Gastrointestinal cancer is a term for the group of cancers that affect the digestive system. These cancers occurs when abnormal cells in a specific part of the digestive system grow in an uncontrolled way. Gastrointestinal cancers are not sex-specific.
It is estimated that over 27,000 Australians will be diagnosed with a gastro-intestinal cancer in 2025, including bowel, pancreatic, liver, stomach and oesophageal cancers.*
What are the types of gastrointestinal cancer?
- Oesophageal cancer
- Liver cancer
- Stomach cancer
- Gallbladder & biliary tract cancer
- Pancreatic cancer
- Gastro-intestinal stromal tumour (GIST)
- Neuroendocrine tumours (NETs)
- Colorectal cancer
- Small bowel cancer
- Anal cancer
What are the common symptoms of gastrointestinal cancer?
Some types of gastrointestinal cancer can be symptomless, making it difficult to detect in the early stages. However, any changes to the way your digestive system feels or operates should be discussed with your GP. Depending on the type of GI cancer, symptoms may include:
- Stomach pain or bloating
- Feeling of stomach fullness
- Heartburn
- Indigestion
- Persistent nausea and vomiting
- Loss of appetite
- Unintentional weight Loss
- Fatigue
How are gastro-intestinal cancers diagnosed?
The diagnosis of GI cancers vary depending on the type of cancer that is suspected. Your GP will perform an initial examination and may conduct a blood test. If necessary, they may then refer you for further tests. These might include:
- An endoscopy to check the lining of the esophagus, stomach, and small intestine for tumors
- A colonoscopy to check the colon and rectum for polyps
- Imaging studies (MRI, X-ray, ultrasound, CT scan or PET scan) to check for abnormal tissue anywhere in the digestive system.
- An endoscopic ultrasound
- A biopsy to obtain a sample of abnormal tissue and analyse it for the presence of cancer cells.
What is the prognosis for gastrointestinal cancer?
The prognosis for gastrointestinal cancer varies greatly, depending on which organ or area of the body is affected, and the stage of the cancer.
An individual's prognosis also depends on the age and general health of the person at the time of diagnosis. Treatment is most effective if the cancer is found in its early stages.
Let's stay in touch
To receive updates on our work, campaigns and our impact in cancer research, subscribe to our newsletter.
